Lawsuits

Dan Bilzerian, CEO of Ignite International Brands Ltd, is being sued by the company’s former executive vice president who claims he was fired after blowing the whistle on irresponsible spending.

Cannabis companies are paying insurance rates that are up to seven times higher than other industries with many citing a rise in U.S. lawsuits against publicly traded cannabis firms.

Brian Lannon, the co-founder and former CEO for Cannalysis, a California testing lab, has filed suit against the company over allegations of wrongful termination, fraudulent activities, and more.

Florida MCBD is suing New York-based Columbia Care claiming a pattern of wrongful interference as Columbia worked to secure a Florida cannabis business license.

Harborside in California is continuing its challenge of the federal tax code 280E, which the company’s legal team says is unconstitutional and runs afoul of the 16th Amendment.

The Maine Cannabis Coalition is suing the state over its recent decision to remove residency requirements for cannabis licensees.

A RICO case brought by an Oregon homeowner against more than 80 cannabis companies has been dismissed at the plaintiff’s request.

Lawsuits tied to a 2018 crackdown on Tennessee CBD retailers can move forward after a court rejected a request by law enforcement officials to have the case thrown out.

Oregonized Hemp Co. is suing two different sheriffs’ offices claiming that they unlawfully seized and destroyed $2 million worth of the company’s industrial hemp crop.

The number of class action lawsuits filed against publicly traded cannabis companies more than doubled from 2018 to 2019.

iAnthus Capital Holdings is facing a class-action lawsuit after the company announced it would default on interest payments for a $157.5 million debt.

The Social Equity and Workers Association is suing Los Angeles over the city’s first-come, first-served cannabis licensing process.

A Massachusetts judge ruled that Gov. Baker acted within his authority when he ordered adult-use cannabis dispensaries to close during the coronavirus pandemic.

A former Amazon employee who was fired for using medical cannabis has won a federal court decision that will send the resulting lawsuit back to New Jersey’s Supreme Court, where he has a much stronger shot at winning the case.

Massachusetts Gov. Charlie Baker is being sued for shutting down the state’s adult-use cannabis dispensaries amid the coronavirus pandemic.

Oregon regulators have levied a $110,000 fine on Cura Cannabis, the state’s largest cannabis company, for allegedly mislabeling vape products; some residents have also filed a lawsuit against the company.

License applicants who were rejected due to a glitch in the Department of Health website are hoping to have the chance to resubmit and be reconsidered via a merit-based system.

Canada’s Tilray was targeted by a $300 million lawsuit from Florida soap company Trimax, who accused the cannabis company of trying to bankrupt one of their subsidiaries in hopes of getting a cheaper acquisition.

A former Amazon employee in New Jersey who was fired after failing a drug test for cannabis is suing the online retail giant under a recent state law that prohibits employers from punishing employees for the legal use of medical cannabis.

Multiple U.S. students studying to become nurses or other medical professionals have filed lawsuits against schools that enacted punishments against them for their use of medical cannabis.

Four medical cannabis patients in Massachusetts have asked to join a lawsuit challenging the state’s four-month vaporizer ban approved last month by Gov. Charlie Baker.

Quebec’s government announced it will appeal a recent court decision that ruled the province’s ban on home cannabis cultivation is unconstitutional.

The Pennsylvania American Civil Liberties Union filed suit against Lebanon County after officials decided to stop allowing people who are on parole or probation from participating in the state medical cannabis program.

A class-action lawsuit against Sundial Growers Inc. in Canada claims the company’s U.S. stock prices were affected by an unreported incident where $1.9 million worth of cannabis was returned to the company due to poor quality.